Hawkins (NASDAQ:HWKN) Upgraded by Wall Street Zen to “Buy” Rating

Hawkins (NASDAQ:HWKNGet Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

Other equities research analysts have also recently issued reports about the company. CJS Securities started coverage on Hawkins in a report on Tuesday, April 1st. They set a “market outperform” rating and a $125.00 price target on the stock. BWS Financial restated a “buy” rating and set a $160.00 price objective on shares of Hawkins in a research report on Thursday, May 15th.

Get Our Latest Stock Report on HWKN

Hawkins Stock Performance

Hawkins stock opened at $137.28 on Friday. The company has a quick ratio of 1.37, a current ratio of 2.15 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $2.86 billion, a P/E ratio of 33.98, a PEG ratio of 2.31 and a beta of 0.85. The stock’s 50 day moving average is $127.29 and its 200 day moving average is $118.51. Hawkins has a twelve month low of $87.24 and a twelve month high of $140.58.

Hawkins (NASDAQ:HWKNGet Free Report) last issued its earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 EPS for the quarter, beating the consensus estimate of $0.74 by $0.04. The business had revenue of $245.32 million for the quarter, compared to the consensus estimate of $230.69 million. Hawkins had a return on equity of 18.93% and a net margin of 8.66%. On average, equities research analysts predict that Hawkins will post 4 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Strs Ohio purchased a new position in Hawkins in the first quarter worth about $816,000. Intech Investment Management LLC grew its position in Hawkins by 8.4% in the first quarter. Intech Investment Management LLC now owns 39,511 shares of the specialty chemicals company’s stock worth $4,185,000 after acquiring an additional 3,060 shares in the last quarter. Jane Street Group LLC grew its position in Hawkins by 83.2% in the first quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock worth $4,069,000 after acquiring an additional 17,447 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Hawkins by 9.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock worth $5,590,000 after acquiring an additional 4,400 shares in the last quarter. Finally, Uniplan Investment Counsel Inc. grew its position in Hawkins by 0.5% in the first quarter. Uniplan Investment Counsel Inc. now owns 36,047 shares of the specialty chemicals company’s stock worth $3,818,000 after acquiring an additional 195 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company’s stock.

About Hawkins

(Get Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Recommended Stories

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.